{
    "nct_id": "NCT05820711",
    "official_title": "A Phase I Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Xerostomia After Radiation Therapy for Head and Neck Cancer",
    "inclusion_criteria": "* History of histological diagnosis of head and neck cancer (HNC) that was treated with radiation therapy and currently clinically or radiologically no evidence of disease (NED)\n* Xerostomia, defined as patient reported salivary function (pre-treatment) ≤ 80% of healthy (pre-radiation)\n* ≥ 18 years of age, ≤ 90 years of age.\n* Patients ≥ 2 years from completion of radiation therapy for HNC\n* Karnofsky performance status ≥ 70, patient eligible for bone marrow aspirate with wakeful anesthesia\n* Willing and able to give informed consent\n* Radiographically confirmed submandibular gland(s)\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 90 Years",
    "exclusion_criteria": "* Salivary gland disease (i.e., sialolithiasis)",
    "miscellaneous_criteria": ""
}